The Effect of Combined Bilateral Infraorbital and Infratrochlear Nerve Block in Nasal Surgeries
Combined Bilateral Infraorbital and Infratrochlear Nerve Block Versus Conventional Systemic Analgesia for Patients Undergoing Nasal Surgeries
1 other identifier
interventional
40
1 country
1
Brief Summary
The aim of the study is to assess the efficacy of adding a pre-emptive combined bilateral infraorbital and infratrochlear nerve blocks with bupivacaine 0.25% in decreasing intraoperative and postoperative analgesics consumption and maintaining intraoperative hemodynamic stability during nasal surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2023
CompletedFirst Posted
Study publicly available on registry
December 18, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedDecember 4, 2024
December 1, 2024
6 months
December 8, 2023
December 1, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Total amount of intraoperative fentanyl
throughout the surgery
Secondary Outcomes (6)
1. Hemodynamic changes
every 15 minutes during the surgery, upon arrival to the PACU and after 30 min.
The time from induction of anesthesia to the first additional dose of fentanyl intraoperative.
throughout the surgery
Total amount of postoperative pethidine given
24 hours postoperatively
Number of patients needed rescue analgesia intraoperative or postoperative.
throughout the surgery and 24 hours postoperatively
Any complications related to the nerve block such as injection site pain, edema, hematoma or neurological deficits in the blocked area such as paresthesia or prolonged paralysis of the upper lip.
24 hours postoperatively
- +1 more secondary outcomes
Study Arms (2)
Study group
ACTIVE COMPARATORpatients will receive combined bilateral infraorbital and infratrochlear nerve block. 20 patients
control group
NO INTERVENTIONpatients will not receive the block and will receive intravenous analgesia according to standard protocol. 20 patients.
Interventions
Filling the block labelled syringe with 8 mL of bupivacaine 0.25%. Starting with Infraorbital nerve block using an extraoral approach.Inserting a 25-gauge needle laterally to the ipsilateral nostril after palpating the infraorbital ridge to locate the infraorbital foramen. Positioning of the index finger of the non-dominant hand above the infraorbital foramen and advancing the needle feeling it beneath the finger to avoid globe penetration injury. Injecting 3 mL of the study solution slowly after confirming negative aspiration of blood and taking care not to inject into the foramen itself. Shifting to infratrochlear nerve block by inserting the needle 1 cm above the inner canthus targeting the junction of the orbit and the nasal bone. Injecting 1mL of the study solution after confirming negative aspiration of blood. Performing contralateral nerve block in the same manner. Applying pressure to four injection points for one minute to prevent hematoma.
Eligibility Criteria
You may qualify if:
- Age group: 18 - 55 years old.
- American Society of Anesthesiologists (ASA) Physical Status Class I or II
- Scheduled for elective nasal surgery under general anesthesia.
You may not qualify if:
- Refusing to participate in the study or inability to provide informed consent.
- History of allergy to the medications used in the study.
- Contraindications to regional anesthesia (including coagulopathy, INR ≥ 1.4 and local infection).
- Compromised renal or liver functions.
- History of substance or alcohol abuse.
- Pre-existing chronic pain of different etiology.
- Psychiatric disorders.
- Pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain shams university hospitals
Cairo, Cairo Governorate, 002, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Ayat Elshaer, ass.lecturer
faculty of medicine, Ain Shams University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant lecturer of anesthesia
Study Record Dates
First Submitted
December 8, 2023
First Posted
December 18, 2023
Study Start
January 1, 2024
Primary Completion
July 1, 2024
Study Completion
September 1, 2024
Last Updated
December 4, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share